Form 424B5 Atara Biotherapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
ATARA Biotherapeutics supplements prospectus for stock offering
May 12, 2026 4:44 PM EDT(Updated - May 12, 2026 4:46 PM EDT)
ATARA Biotherapeutics Inc. (NASDAQ: ATRA) filed a prospectus supplement that allows the company to continue offering common stock under its existing sales agreement despite changes in regulatory requirements.
The biotechnology company filed the second supplement to its sales agreement... More



